Literature DB >> 2476078

Early diagnosis and secondary prevention of Duchenne muscular dystrophy.

R A Smith1, J R Sibert, S J Wallace, P S Harper.   

Abstract

A total of 33 young boys (mean age 3.4 years) with Duchenne muscular dystrophy and 21 normal controls (mean age 3.5 years) were assessed using the Griffiths's mental development scales and the Reynell language scales. The boys with Duchenne muscular dystrophy were significantly developmentally delayed when compared with the control group. The developmental delay was most pronounced in locomotor function and language. There was no significant difference in social class distribution. Early diagnosis of Duchenne muscular dystrophy is of vital importance if secondary cases within families are to be prevented. While diagnosis is still unacceptably late in most cases, it can be improved if all boys with this pattern of developmental delay are screened for Duchenne muscular dystrophy by measurement of creatine kinase activity.

Entities:  

Mesh:

Year:  1989        PMID: 2476078      PMCID: PMC1792549          DOI: 10.1136/adc.64.6.787

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

1.  Evidence of early impairment of verbal intelligence in Duchenne muscular dystrophy.

Authors:  G G Marsh; T L Munsat
Journal:  Arch Dis Child       Date:  1974-02       Impact factor: 3.791

2.  Screening the newborn for Duchenne muscular dystrophy: parents' views.

Authors:  M A Firth; E J Wilkinson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-18

3.  Recognising and preventing Duchenne muscular dystrophy.

Authors:  D Gardner-Medwin
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

4.  Implications of diagnostic delay in Duchenne muscular dystrophy.

Authors:  T O'Brien; J R Sibert; P S Harper
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

5.  Diagnostic delay in Duchenne's muscular dystrophy.

Authors:  D E Crisp; F A Ziter; P F Bray
Journal:  JAMA       Date:  1982 Jan 22-29       Impact factor: 56.272

6.  Bone disease after jejuno-ileal bypass for obesity.

Authors:  J E Compston; L W Horton; M F Laker; A B Ayers; J S Woodhead; H J Bull; J C Gazet; T R Pilkington
Journal:  Lancet       Date:  1978-07-01       Impact factor: 79.321

7.  [Newborn screening for Duchenne muscular dystrophy (author's transl)].

Authors:  T Grimm
Journal:  Monatsschr Kinderheilkd       Date:  1981-07       Impact factor: 0.323

8.  Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy.

Authors:  S M Forrest; T J Smith; G S Cross; A P Read; N S Thomas; R C Mountford; P S Harper; R T Geirsson; K E Davies
Journal:  Lancet       Date:  1987-12-05       Impact factor: 79.321

9.  Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy.

Authors:  L M Drummond
Journal:  Arch Dis Child       Date:  1979-05       Impact factor: 3.791

10.  Coronary heart-disease after treatment of hypertension.

Authors:  G Berglund; R Sannerstedt; O Andersson; H Wedel; L Wilhelmsen; L Hansson; R Sivertsson; J Wikstrand
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

View more
  7 in total

1.  Duchenne muscular dystrophy: relevant paper was not included.

Authors:  R A Smith; R S Phillips
Journal:  BMJ       Date:  2001-11-24

Review 2.  Evidence based case report: Assessing developmental delay.

Authors:  J Dorling; A Salt
Journal:  BMJ       Date:  2001-07-21

3.  Two children with muscular dystrophies ascertained due to referral for diagnosis of autism.

Authors:  Lonnie Zwaigenbaum; Mark Tarnopolsky
Journal:  J Autism Dev Disord       Date:  2003-04

Review 4.  Should creatine kinase be checked in all boys presenting with speech delay?

Authors:  Claire T Lundy; Gary M Doherty; Elaine M Hicks
Journal:  Arch Dis Child       Date:  2007-07       Impact factor: 3.791

5.  Reproductive patterns among mothers of males diagnosed with Duchenne or Becker muscular dystrophy.

Authors:  Sarah K Nabukera; Paul A Romitti; Kristin M Caspers; Natalie Street; Christopher Cunniff; Katherine D Mathews; Deborah J Fox; Soman Puzhankara; Emma Ciafaloni; Katherine A James; Yin Su
Journal:  Am J Med Genet A       Date:  2012-12-13       Impact factor: 2.802

6.  Attitudes of mothers to neonatal screening for Duchenne muscular dystrophy.

Authors:  R A Smith; D K Williams; J R Sibert; P S Harper
Journal:  BMJ       Date:  1990-04-28

7.  Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).

Authors:  Emma Ciafaloni; Deborah J Fox; Shree Pandya; Christina P Westfield; Soman Puzhankara; Paul A Romitti; Katherine D Mathews; Timothy M Miller; Dennis J Matthews; Lisa A Miller; Christopher Cunniff; Charlotte M Druschel; Richard T Moxley
Journal:  J Pediatr       Date:  2009-04-25       Impact factor: 4.406

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.